A clear and present danger: inflammasomes DAMPing down disorders of pregnancy
Authors:
Open Access
- 17 November 2014
- journal article
- review article
- Published by Oxford University Press (OUP) in Human Reproduction Update
- Vol. 21 (3) , 388-405
Abstract
When the normal progression of pregnancy is threatened, inflammatory processes are often amplified in order to minimize detrimental effects and eliminate noxious agents. Inflammasomes are unique, intracellular, multiprotein assemblies that enable caspase-1 mediated proteolytic processing of the proinflammatory cytokine interleukin-1β, levels of which are elevated in some forms of preterm birth and maternal metabolic disorders. A comprehensive review based on a search of PubMed and Medline for terms and combinations of terms incorporating ‘inflammation’, ‘inflammasome’, ‘pregnancy’, ‘preterm birth’, ‘pre-eclampsia’, ‘interleukin-1’, ‘caspase-1’ and others selected to capture key articles. In the decade since the discovery of the inflammasome, between January 2002 and June 2014 over 2200 articles have been published. Articles in the reproductive field are scarce but there is clear evidence for a role of the inflammasome axis in pregnancy, preterm birth and the maternal metabolic syndrome. Further investigations on the inflammasome in pregnancy are needed in order to elucidate the biology of this unique structure in reproduction. Coordination of maternal, fetal and placental aspects of inflammasome function will potentially yield new information on the detection and transduction of host and non-host signals in the inflammatory response.Keywords
This publication has 242 references indexed in Scilit:
- Rapid induction of inflammatory lipid mediators by the inflammasome in vivoNature, 2012
- The Nlrp3 inflammasome: contributions to intestinal homeostasisTrends in Immunology, 2011
- Inflammasome and IL-1β-Mediated DisordersCurrent Allergy and Asthma Reports, 2010
- NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystalsNature, 2010
- The InflammasomesCell, 2010
- A pilot study to evaluate the safety and efficacy of the long‐acting interleukin‐1 inhibitor rilonacept (interleukin‐1 trap) in patients with familial cold autoinflammatory syndromeArthritis & Rheumatism, 2008
- The NLR Gene Family: A Standard NomenclatureImmunity, 2008
- Epidemiology and causes of preterm birthThe Lancet, 2008
- Molecular identification of a danger signal that alerts the immune system to dying cellsNature, 2003
- A novel heterodimeric cysteine protease is required for interleukin-1βprocessing in monocytesNature, 1992